Personal Products Stocks

Proctor & Gamble Annual Valuation – 2015 $PG

Procter_&_Gamble_logo_2013

Procter & Gamble does not qualify for either the Defensive Investor or the Enterprising Investor. The Defensive Investor is concerned with the low current ratio, insufficient earnings growth over the last ten years, and high PEmg and PB ratios. The Enterprising Investor takes issue with the level of debt relative to the current assets along with the lack of earnings growth over the last five years. As a result, any purchase of the company is made with a speculative nature behind it. That said, any speculator interested in pursuing the company should still proceed to the next part of the analysis, which is a determination of the company’s intrinsic value.

With regard to that intrinsic value, the company has seen its EPSmg (normalized earnings) drop from $3.95 in 2011 to only an estimated $3.89 for 2015. This lack of demonstrated growth does not support the market’s implied estimate for earnings growth of 6.78% annually over the next 7-10 years. The ModernGraham valuation model therefore returns an estimate of intrinsic value below the current price, indicating the company is overvalued at the present time.

Be sure to check out previous ModernGraham valuations of Proctor & Gamble (PG) for greater perspective!

Read the full valuation on Seeking Alpha!

PG Chart

PG data by YCharts

Disclaimer:  The author did not hold a position in Proctor & Gamble (PG) at the time of publication and had no intention of changing that position within the next 72 hours.  Logo taken from Wikipedia for the sole purpose of identifying the company; this article is not affiliated with the company in any manner.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back To Top